
GeneOne Life Science, Inc.
KRX:011000.KS
Overview | Financials
Company Name | GeneOne Life Science, Inc. |
Symbol | 011000.KS |
Currency | KRW |
Price | 2,070 |
Market Cap | 165,247,139,520 |
Dividend Yield | 0% |
52-week-range | 1,835 - 4,735 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Young-Keun Park J.D., M.B.A. |
Website | https://www.genels.com |
An error occurred while fetching data.
About GeneOne Life Science, Inc.
GeneOne Life Science, Inc., a biopharmaceutical company, engages in the development and contract manufacturing of gene-based-biomedicines. Its products comprise GLS-1027, which is in Phase I clinical trial for treatment of nephropathy and inflammatory diseases; GLS-1200 that is in Phase II clinical trial to treat Rhinosinusitis; GLS-1027 and GLS-1200, which is
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD